WeMed Medical Abtained The Best-performing Outbound Strategic Layouts Award

BEIJING --- The case of WeMed Medical's global dual-center strategic layout was awarded The Best-performing Outbound Strategic Layouts last week.

WeMed Medical was established in 2014, and has gradually grown from a small business to today's scale. The main business is to provide full solutions of Digital Subtraction Angiography System, Mobile DSA System, Mobile C arm X-ray Machine, and Interventional Robot. It is a hard technology enterprise with more than 100 patents, 80% of which are invention patents.

WeMed Medical adheres to the concept of "Innovation For Health", and perfectly creates a big family of "new domestic products" for intervention therapy. These new products and technologies are used in various fields such as cardiac intervention, neuro intervention, comprehensive intervention, peripheral vascular intervention, and tumor intervention.

In July 2022, the collection of medical device innovation cases overseas began that was organized by VBDATA.cn, VB100, and VCBeat Research. This competition is based on the development ecology of the overseas market of medical devices, from three perspectives: product innovation, strategic layout, and enabling services. Focus on assessing the innovation points, outstanding advantages, achievements, roles, and contributions of each participant, and the significance of the case for the medical device going overseas in the case submitted by the participating units in the review year.

We are closely following the “The Belt and Road" strategy. completed the acquisition of EC through various forms such as overseas mergers and acquisitions. Created a global dual center to realize the international strategic layout of product research and development, manufacturing and marketing.